T1	Entity 161 184	Tripeptidyl-peptidase I
T2	KeyEntity 200 204	CLN2
T3	Entity 235 245	sedolisins
T4	Entity 247 273	serine-carboxyl peptidases
T5	Entity 334 365	fatal neurodegenerative disease
T6	Entity 377 422	late-infantile neuronal ceroid lipofuscinosis
R1	other_relation Arg1:T2 Arg2:T1	
#1	AnnotatorNotes R1	equivalent
R2	other_relation Arg1:T4 Arg2:T3	
#2	AnnotatorNotes R2	equivalent
T7	KeyEntity 682 686	CLN2
T8	Entity 1081 1110	Pseudomonas sp. 101 sedolisin
T9	Entity 999 1036	three-dimensional model of human CLN2
R3	participates_in Arg1:T8 Arg2:T9	
T10	KeyEntity 1125 1129	CLN2
T11	Entity 1138 1154	highly conserved
T12	Entity 1159 1177	widely distributed
T13	Entity 1380 1392	CLN2 enzymes
T14	Entity 1336 1363	almost completely conserved
T15	Entity 1434 1446	tripeptidase
T16	Entity 1649 1676	specific inhibitors of CLN2
R4	participates_in Arg1:T10 Arg2:T11	
R5	participates_in Arg1:T10 Arg2:T12	
R6	participates_in Arg1:T13 Arg2:T14	
